Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

CALM IVF (Criando afiliações, aprendizado e atenção plena para pacientes de fertilização in vitro)

30 de setembro de 2026 atualizado por: University of Iowa

Criando afiliações, aprendizado e atenção plena para pacientes de fertilização in vitro

The investigators have designed a psychoeducational group curriculum specifically for new in vitro fertilization (IVF) patients (both male and female) to improve their treatment knowledge, to allow them to engage more in their care, to offer a support network, to improve satisfaction, and to provide them with tools to help reduce their stress and anxiety while undergoing the IVF process. The investigators plan to have four to eight infertility patients and their partners participate in a group at a time, for which they will attend three 1-1.5 hour interactive sessions that are scheduled throughout their first IVF cycle. These sessions will provide additional time for discussion about treatment with providers, learning opportunities on topics of interest to fertility patients, and stress reduction techniques. They will do several surveys before and after the intervention for comparison, including assessment of quality of life, depression, anxiety, resilience, and a knowledge assessment. The investigators will also track the patients to see if they pursue additional treatment in the instance of a negative pregnancy test compared to patients undergoing the standard treatment. The investigators plan to recruit a control group that receives the standard of care treatment here at the University of Iowa.

Visão geral do estudo

Descrição detalhada

Patients and their partners (if present and consenting) will be randomized in a 2:1 fashion to two different treatment arms: A) standard of care in vitro fertilization (IVF) at the investigational institution as well as participating in an additional psychoeducational group or B) standard of care IVF at the investigational institution. The intervention group will consist of three additional evening visits for 1-1.5 hours per session. The sessions will include an interactive educational component addressing usual questions and concerns of IVF patients, such as reviewing common IVF myths, and also more information regarding treatment and technologies. Each session will also include teaching of coping strategies (such as awaiting the pregnancy test, how to cope with insensitive remarks from friends and family) as well as relaxation exercises, such as progressive muscle relaxation and deep breathing.

The patients will be consented at their new IVF visit and will take their initial assessments (FertiQoL, GAD-7, PHQ-9, the Connor-Davidson Resilience Scale, and a knowledge assessment) within 24 hours of the new visit. The patients will be assigned into groups based on when they are going through their IVF stimulations, so they will have similar experiences at similar times. Patients will take their final assessments on the third day after egg retrieval, regardless of group assignment.

When partners are present and consent to the study, they will be treated as a dyad with the patient undergoing oocyte retrieval. Some patients go through treatment alone (i.e. single adults desiring pregnancy) and therefore may not have a partner available to participate. Partners level of involvement in a cycle may very, as may their desire to participate in a psychosocial intervention. As patients and their partners make joint decisions throughout their IVF cycle and the cycle itself has a single outcome, we enrolled partners as dyads with patients when partners were present, but did not require a partner to enroll a patient.

Tipo de estudo

Intervencional

Inscrição (Real)

117

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Iowa
      • Iowa City, Iowa, Estados Unidos, 52242
        • University of Iowa Hospitals and Clinics

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 99 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • All patients starting their first in vitro fertilization cycle at the University of Iowa Hospitals and Clinics

Exclusion Criteria:

  • Patients who have already undergone in vitro fertilization treatment at any institution
  • Non-English speakers
  • Fertility preservation patients
  • Patients using donor oocytes, embryos, or sperm
  • Patients taking psychotropic medications for depression or anxiety that have had a dosing adjustment within 3 months of study enrollment

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Intervention

Standard of care in vitro fertilization patients randomized to the psychoeducational group intervention.

The intervention will be three 1-1.5 hour interactive sessions that are scheduled throughout the participant's first in vitro fertilization cycle. These sessions will provide additional time for discussion about treatment with providers, learning opportunities on topics of interest to fertility patients, and stress reduction techniques.

Outro: Control

Standard of care in vitro fertilization patients at our institution.

Patients will receive the standard of care IVF treatment at the University of Iowa.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Change in female fertility patient quality of life score during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval

FertiQoL International (Fertility Quality of Life Questionnaire 2008), scored scale from 0-100, with higher values indicating a higher quality of life and low scores indicating a lower quality of life.

From enrollment to 2-4 days after oocyte retrieval

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Change in female GAD-7 score during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval

Generalized Anxiety Disorder 7-item scale, with higher scores indicating higher likelihood of an anxiety disorder and lower scores indicating less likelihood of an anxiety disorder.

From enrollment to 2-4 days after oocyte retrieval
Change in female PHQ-9 score during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval

Patient Health Questionnaire, with higher score indicating increased likelihood of a depressive disorder and lower scores indicating less likelihood of a depressive disorder.

From enrollment to 2-4 days after oocyte retrieval
Change in female Connor-Davidson Resilience Scale during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval

Connor-Davidson Resilience Scale, with higher scores indicating greater resilience, and lower scores indicating lower resilience

From enrollment to 2-4 days after oocyte retrieval
Change in female knowledge assessment during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval

Assessment of knowledge regarding IVF treatment, with higher scores indicating a greater knowledge of IVF treatment, and lower scores indicating less knowledge regarding IVF treatment

From enrollment to 2-4 days after oocyte retrieval
Likelihood of continued IVF treatment in the instance of a negative pregnancy test
Prazo: Three months after embryo transfer

Patients who are not pregnant after embryo transfer will be followed for three months to assess likelihood to return for additional treatment after negative embryo transfer outcome.

Three months after embryo transfer
Change in male fertility patient quality of life score during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval

FertiQoL International (Fertility Quality of Life Questionnaire 2008), scored scale from 0-100, with higher values indicating a higher quality of life and low scores indicating a lower quality of life.

From enrollment to 2-4 days after oocyte retrieval
Change in male GAD-7 score during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval

Generalized Anxiety Disorder 7-item scale, with higher scores indicating higher likelihood of an anxiety disorder and lower scores indicating less likelihood of an anxiety disorder.

From enrollment to 2-4 days after oocyte retrieval
Change in male PHQ-9 score during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval

Patient Health Questionnaire, with higher score indicating increased likelihood of a depressive disorder and lower scores indicating less likelihood of a depressive disorder.

From enrollment to 2-4 days after oocyte retrieval
Change in male Connor-Davidson Resilience Scale during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval

Connor-Davidson Resilience Scale, with higher scores indicating greater resilience, and lower scores indicating lower resilience

From enrollment to 2-4 days after oocyte retrieval
Change in male knowledge assessment during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval

Assessment of knowledge regarding IVF treatment, with higher scores indicating a greater knowledge of IVF treatment, and lower scores indicating less knowledge regarding IVF treatment

From enrollment to 2-4 days after oocyte retrieval

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Rachel M Whynott, MD, University of Iowa

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

9 de agosto de 2019

Conclusão Primária (Real)

9 de agosto de 2021

Conclusão do estudo (Real)

26 de outubro de 2021

Datas de inscrição no estudo

Enviado pela primeira vez

5 de agosto de 2019

Enviado pela primeira vez que atendeu aos critérios de CQ

5 de agosto de 2019

Primeira postagem (Real)

7 de agosto de 2019

Atualizações de registro de estudo

Última Atualização Postada (Real)

2 de outubro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

30 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever